Get the app today! Download iPhone App Download Android App

Pasta Maker Barilla Funds Cell Therapy Research For Coronavirus

Published on Apr 14 2020 2:59 PM in Coronavirus tagged: Trending Posts / Italy / Barilla / COVID-19 / USFDA

Pasta Maker Barilla Funds Cell Therapy Research For Coronavirus

The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to US non-profit association 'The Cure Alliance' to fund research on a COVID-19 therapy based on stem cells, the group has said.

The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the US Food and Drug Administration, Barilla said.

A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.

The money adds to a previous €2 million ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company's home country.

News by ReutersClick subscribe to sign up to ESM: European Supermarket Magazine.

Share on Facebook Share on Twitter Share on LinkedIn Share via Email